| Application no. and date | 16869289.5 (espacenet) (Federated) (European Patent Register), 20161123 | | Patent/reg. no. and date | DK/EP 3380525, 20231108 | | Publication date | 20181003 | | Priority no. and date | US 201562260104 P, 20151125, US 201662368156 P, 20160728 | | EP pub. no. and date |
EP 3380525 20181003 | | Effective date | | | Applicant/owner | Immunogen, Inc., 830 Winter Street
Waltham, MA 02451, US | | Applicant ref. no. | PE959139DKQ | | Inventor | BARTLETT, Elizabeth, 88 Park Avenue
Unit 207
Arlington, MA 02476, US | | Representative | Marks & Clerk LLP, 44, rue de la Vallée
L-2661 Luxembourg, LU | | Opponent | | | IPC Class | C07D 487/04 (2006.01) , C07K 16/28 (2006.01) , C07K 16/46 (2006.01) | | Title | FARMACEUTISKE FORMULERINGER OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | | Int. application no. | US2016063624 | | Int. publication no. | WO2017091745 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
